Detalles de la búsqueda
1.
Impaired neurocognitive functioning 3 months following diagnosis of high-risk acute lymphoblastic leukemia: A report from the Children's Oncology Group.
Pediatr Blood Cancer
; 70(7): e30350, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37129114
2.
Prognostic impact of minimal residual disease at the end of consolidation in NCI standard-risk B-lymphoblastic leukemia: A report from the Children's Oncology Group.
Pediatr Blood Cancer
; 68(4): e28929, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33559396
3.
Targetable kinase gene fusions in high-risk B-ALL: a study from the Children's Oncology Group.
Blood
; 129(25): 3352-3361, 2017 06 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-28408464
4.
Replacing cyclophosphamide/cytarabine/mercaptopurine with cyclophosphamide/etoposide during consolidation/delayed intensification does not improve outcome for pediatric B-cell acute lymphoblastic leukemia: a report from the COG.
Haematologica
; 104(5): 986-992, 2019 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-30545921
5.
Toxicity associated with intensive postinduction therapy incorporating clofarabine in the very high-risk stratum of patients with newly diagnosed high-risk B-lymphoblastic leukemia: A report from the Children's Oncology Group study AALL1131.
Cancer
; 124(6): 1150-1159, 2018 03 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-29266189
6.
Prognostic significance of minimal residual disease in high risk B-ALL: a report from Children's Oncology Group study AALL0232.
Blood
; 126(8): 964-71, 2015 Aug 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-26124497
7.
Outstanding outcomes in infants with KMT2A-germline acute lymphoblastic leukemia treated with chemotherapy alone: results of the Children's Oncology Group AALL0631 trial.
Haematologica
; 107(5): 1205-1208, 2022 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35172563
8.
A Pilot Study of Intensified PEG-Asparaginase in High-risk Acute Lymphoblastic Leukemia: Children's Oncology Group Study AALL08P1.
J Pediatr Hematol Oncol
; 38(6): 409-17, 2016 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-27299599
9.
Erwinia asparaginase achieves therapeutic activity after pegaspargase allergy: a report from the Children's Oncology Group.
Blood
; 122(4): 507-14, 2013 Jul 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-23741010
10.
Decreased induction morbidity and mortality following modification to induction therapy in infants with acute lymphoblastic leukemia enrolled on AALL0631: a report from the Children's Oncology Group.
Pediatr Blood Cancer
; 62(3): 414-8, 2015 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-25407157
11.
Intensified chemotherapy without SCT in infant ALL: results from COG P9407 (Cohort 3).
Pediatr Blood Cancer
; 62(3): 419-26, 2015 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-25399948
12.
Impact of Propofol Exposure on Neurocognitive Outcomes in Children With High-Risk B ALL: A Children's Oncology Group Study.
J Clin Oncol
; : JCO2301989, 2024 Apr 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-38603641
13.
Outcomes in Children, Adolescents, and Young Adults With Down Syndrome and ALL: A Report From the Children's Oncology Group.
J Clin Oncol
; 42(2): 218-227, 2024 Jan 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37890117
14.
Racial and ethnic disparities in childhood and young adult acute lymphocytic leukaemia: secondary analyses of eight Children's Oncology Group cohort trials.
Lancet Haematol
; 10(2): e129-e141, 2023 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-36725118
15.
Modifications to induction therapy decrease risk of early death in infants with acute lymphoblastic leukemia treated on Children's Oncology Group P9407.
Pediatr Blood Cancer
; 59(5): 834-9, 2012 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-22488662
16.
Plasma methotrexate, red blood cell methotrexate, and red blood cell folate values and outcome in children with precursor B-acute lymphoblastic leukemia: a report from the Children's Oncology Group.
J Pediatr Hematol Oncol
; 34(1): e1-7, 2012 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-21364468
17.
Outcomes in adolescent and young adult patients (16 to 30 years) compared to younger patients treated for high-risk B-lymphoblastic leukemia: report from Children's Oncology Group Study AALL0232.
Leukemia
; 36(3): 648-655, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34725453
18.
FLT3 inhibitor lestaurtinib plus chemotherapy for newly diagnosed KMT2A-rearranged infant acute lymphoblastic leukemia: Children's Oncology Group trial AALL0631.
Leukemia
; 35(5): 1279-1290, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33623141
19.
Tolerability and efficacy of L-asparaginase therapy in pediatric patients with acute lymphoblastic leukemia.
J Pediatr Hematol Oncol
; 32(7): 554-63, 2010 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-20724951
20.
Impact of Asparaginase Discontinuation on Outcome in Childhood Acute Lymphoblastic Leukemia: A Report From the Children's Oncology Group.
J Clin Oncol
; 38(17): 1897-1905, 2020 06 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32275469